Historical record - last NADAC publication: 6/19/2019
Product Information
THERAFLU NT SEVERE CLD-CGH PKT is a brand product labeled by Haleon US Holdings LLC, priced at $0.9074 per EA under NDC 00067791806. Its NADAC has been published 247 times since Sep 23, 2015.
Strength
650; 25; 10 mg/237mL; mg/237mL; mg/237mL
Manufacturer
Haleon US Holdings LLCNDC
00067791806
Classification
Brand
Dosage Form
POWDER, FOR SOLUTION
Route
ORAL
Last Updated
6/19/2019
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/1/2014
Pharmacological Classes
Price Statistics
The NADAC for THERAFLU NT SEVERE CLD-CGH PKT has been published 247 times since Sep 23, 2015, and over the history we have for it it has risen 10.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9074 per EA |
|---|---|
| All-time high | $0.9074 (Jun 10, 2020) |
| All-time low | $0.8250 (Sep 23, 2015) |
| Median price | $0.8706 |
| Average price | $0.8674 |
| Largest weekly change | +9.7% (Oct 21, 2015) |
| Weeks tracked | 247 |
| Tracking since | Sep 23, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of THERAFLU NT SEVERE CLD-CGH PKT?
The current National Average Drug Acquisition Cost (NADAC) for THERAFLU NT SEVERE CLD-CGH PKT, manufactured by Haleon US Holdings LLC, is $0.9074 per EA (NDC 00067791806), effective Jun 10, 2020.
How has the price of THERAFLU NT SEVERE CLD-CGH PKT changed over time?
Over the history we have for it, the NADAC for THERAFLU NT SEVERE CLD-CGH PKT has risen 10.0%. It has been tracked across 247 weekly CMS publications since Sep 23, 2015.
What are the highest and lowest recorded NADAC prices for THERAFLU NT SEVERE CLD-CGH PKT?
Since Sep 23, 2015, the NADAC for THERAFLU NT SEVERE CLD-CGH PKT has ranged from a low of $0.8250 (Sep 23, 2015) to a high of $0.9074 (Jun 10, 2020), with a median of $0.8706 per EA.
Are there cheaper alternatives to THERAFLU NT SEVERE CLD-CGH PKT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of THERAFLU NT SEVERE CLD-CGH PKT, so no direct lower-cost alternative is listed.
Who manufactures THERAFLU NT SEVERE CLD-CGH PKT?
THERAFLU NT SEVERE CLD-CGH PKT (NDC 00067791806) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification